Login to Your Account

Financings Roundup

Inimex Nets $22M in Series B to Advance Innate Defense Drugs

By Tiffany Turner

Tuesday, June 3, 2008
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription